Cargando…
MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3β/E-cadherin pathway
Although 5-year survival rate of non-metastatic colorectal cancer (CRC) is high, about 10% of patients in stage I and II still develop into metastatic CRC and eventually die after resection. Currently, there is no effective biomarker for predicting the prognosis of non-metastatic CRC in clinical pra...
Autores principales: | Zhou, Chunxian, Cui, Fengyun, Li, Jiali, Wang, Diyi, Wei, Yingze, Wu, Ying, Wang, Jiping, Zhu, Hongguang, Wang, Shuyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564786/ https://www.ncbi.nlm.nih.gov/pubmed/28548936 http://dx.doi.org/10.18632/oncotarget.17743 |
Ejemplares similares
-
miR-224 targets BTRC and promotes cell migration and invasion in colorectal cancer
por: Zheng, Qi, et al.
Publicado: (2020) -
ITCA 650
por: Bertsch, Taylor, et al.
Publicado: (2018) -
Functions and underlying mechanisms of miR-650 in human cancers
por: Su, Yuanshuai, et al.
Publicado: (2022) -
BEBC: 650 000 expansions
Publicado: (1975) -
Sec-O-Glucosylhamaudol Inhibits RANKL-Induced Osteoclastogenesis by Repressing 5-LO and AKT/GSK3β Signaling
por: Cao, Jinjin, et al.
Publicado: (2022)